Evolutionary rescue model informs strategies for driving cancer cell populations to extinction
{"Cancers":[0],"exhibit":[1],"a":[2,9,71,95,113,126,167,170,189,223,242,247],"remarkable":[3],"ability":[4],"to":[5,8,44,50,81,90,107,112,120,125,184,199],"develop":[6],"resistance":[7,39,55,79,165,240],"range":[10],"of":[11,30,35,38,70,74,94,138,147,149,155,161,182,195],"treatments,":[12],"often":[13],"resulting":[14],"in":[15,100,215],"relapse":[16],"following":[17],"first-line":[18],"therapies":[19],"and":[20,33,116,122,163,201,221],"significantly":[21],"worse":[22],"outcomes":[23],"for":[24],"subsequent":[25],"treatments.":[26,85],"While":[27],"our":[28,234],"understanding":[29],"the":[31,36,52,92,110,136,139,142,145,152,156,159,174,180,185,193,197],"mechanisms":[32],"dynamics":[34],"emergence":[37,148],"during":[40],"cancer":[41,198],"therapy":[42,128,204,207],"continues":[43],"advance,":[45],"questions":[46],"remain":[47],"about":[48],"how":[49,132],"minimize":[51],"probability":[53],"that":[54,76,179,202,218,233],"will":[56,226],"evolve,":[57],"thereby":[58],"improving":[59],"long-term":[60],"patient":[61],"outcomes.":[62],"Here,":[63],"we":[64,231,238],"present":[65],"an":[66,214],"evolutionary":[67],"simulation":[68],"model":[69,89,239],"clonal":[72],"population":[73,111],"cells":[75],"can":[77],"acquire":[78],"mutations":[80],"one":[82],"or":[83,169,228,245],"more":[84],"We":[86,130,212],"leverage":[87],"this":[88],"examine":[91],"efficacy":[93],"two-strike":[96],"\\"extinction":[97],"therapy\\"":[98],"protocol,":[99],"which":[101],"two":[102,143],"treatments":[103],"are":[104],"applied":[105,157],"sequentially":[106],"first":[108],"contract":[109],"vulnerable":[114],"state":[115],"then":[117],"push":[118],"it":[119,124],"extinction,":[121,200],"compare":[123],"combination":[127,206],"protocol.":[129],"investigate":[131],"factors":[133],"such":[134],"as":[135,241,246],"timing":[137,181],"switch":[140],"between":[141],"strikes,":[144],"rate":[146],"resistant":[150],"mutations,":[151],"dose":[153],"effects":[154],"drugs,":[158],"presence":[160],"cross-resistance,":[162],"whether":[164,237],"is":[166,210],"discrete":[168,243],"quantitative":[171],"trait":[172,244],"affect":[173],"outcome.":[175],"Our":[176],"results":[177],"show":[178],"switching":[183],"second":[186,224],"strike":[187,225],"has":[188],"marked":[190],"effect":[191],"on":[192],"likelihood":[194],"driving":[196],"extinction":[203],"outperforms":[205],"when":[208,220],"cross-resistance":[209],"present.":[211],"conduct":[213],"silico":[216],"trial":[217],"reveals":[219],"why":[222],"succeed":[227],"fail.":[229],"Finally,":[230],"demonstrate":[232],"conclusions":[235],"hold":[236],"quantitative,":[248],"multi-locus":[249],"trait.":[250]}
Authors
- Robert A. Gatenby (ORCID: https://orcid.org/0000-0002-1621-1510)
- Amjad Dabi (ORCID: https://orcid.org/0000-0002-7259-4608)
- Daniel R. Schrider (ORCID: https://orcid.org/0000-0001-5249-4151)
- Corbin D. Jones (ORCID: https://orcid.org/0000-0001-7281-7130)
- Joel S. Brown (ORCID: https://orcid.org/0000-0001-9255-3355)
Institutions
- Moffitt Cancer Center (US)
- UNC Lineberger Comprehensive Cancer Center
Publication Details
- Journal
- PLoS Computational Biology
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1371/journal.pcbi.1014803
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of General Medical Sciences
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill